7068367

IL-1 beta (Pro-form) Monoclonal Antibody (NJTEN3), FITC, eBioscience™, Invitrogen™

Rat Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

IL-1 beta (Pro-form)

Concentration

0.5 mg/mL

Classification

Monoclonal

Form

Liquid

Regulatory Status

RUO

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Alias

il 1b; IL 1β; IL-1 beta; Il1b; Il-1b; IL-1beta; IL1β; ILN; Interleukin; interleukin 1 beta; Interleukin1 beta; interleukin-1 beta; Interleukin-1b

Gene Symbols

Il1b

Primary or Secondary

Primary

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Gene

Il1b

Clone

NJTEN3

Applications

Flow Cytometry

Conjugate

FITC

Host Species

Rat

Target Species

Mouse

Gene Accession No.

P10749

Gene ID (Entrez)

16176

Isotype

IgG1 κ

Purification Method

Affinity chromatography

Product Type

Antibody

Related Products

Img

Fischer Scientific

7068368

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068373

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7068191

Rat Monoclonal Antibody...

Img

Fischer Scientific

7069170

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068364

Rat Monoclonal Antibody...

Img

Fischer Scientific

7068372

Rat Monoclonal Antibody...

Img

Fischer Scientific

7069106

Rat Monoclonal Antibody...

Img

Fischer Scientific

7069106

Rat Monoclonal Antibody...

Description

  • Description: This NJTEN3 monoclonal antibody reacts with the pro-form of mouse IL-1 beta, which is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells
  • It is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol
  • Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals
  • Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta
  • IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is instead secreted alongside caspase-1 via an alternate and incompletely understood mechanism
  • IL-1 beta signals via the IL-1RI, which is shared with IL-1 alpha
  • These cytokines play important roles in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses
  • Their activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition
  • Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions, giving IL-RA or IL-1 beta neutralizing antibodies potential therapeutical value
  • Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells
  • It is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol
  • Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals
  • Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta
  • IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is instead secreted alongside caspase-1 via an alternate and incompletely understood mechanism
  • Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions.IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha
  • These cytokines play important roles in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses
  • Their activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition
  • Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions, giving IL-RA or IL-1 beta neutralizing antibodies potential therapeutical value.